Skip to main content
NIH funding notice RFA-DA-15-003

Medications Development Centers of Excellence Cooperative Program (U54)

Closed on April 25, 2014.

Posted
January 31, 2014
Close date
April 25, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,308,592 in first-year total cost, median $1,154,296.

Most frequent study sections

  1. Special Emphasis Panel[ZDA1 JXR-D (14)]2

Most frequent institutions

  1. UNIVERSITY OF PENNSYLVANIA1
  2. VIRGINIA COMMONWEALTH UNIVERSITY1
Competing awards under RFA-DA-15-003 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2014Medication Development Center for cocaine Use Disorder1U54DA038999-01MOELLER, FREDERICK GERARDVIRGINIA COMMONWEALTH UNIVERSITY, VA$1,219,693ZDA1
2014Center for the Development of Novel Medications for Cocaine Dependence1U54DA039002-01KAMPMAN, KYLE MATTHEWUNIVERSITY OF PENNSYLVANIA, PA$1,088,899ZDA1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.